Journal of Medicinal Chemistry · 2001 · 290 citations · 5 references
Life SciencesMedicinal ChemistryPharmacologyNeurochemistryNeurodegenerationNeuropharmacologyAlzheimer DiseaseCholinergic NeurochemistryCholinergic PharmacologyEnzyme InhibitionMonoamine NeurochemistryNeurochemical PharmacologyAcetylcholinesterase InhibitorsAche InhibitionAmyloid Beta AggregationAmyloid Beta PeptidesDual-target InhibitorsInhibition Of Amyloid FormationMonoamine Oxidase InhibitionMonoamine Oxidase Inhibitors
A set of 17 coumarin and 2 chromone derivatives with known inhibitory activity toward monoamine oxidase (MAO) A and B were tested as acetylcholinesterase (AChE) inhibitors. All compounds inhibited AChE with values in the micromolar range (3-100 microM). A kinetic study showed that most compounds acted as noncompetitive AChE inhibitors. This finding may be of interest in the context of Alzheimer's disease because recent observations suggest that MAO and AChE inhibition might decrease beta-amyloid deposition.
5
A new and rapid colorimetric determination of acetylcholinesterase activity
George L. Ellman, K. Diane Courtney, Valentino Andres et al. · Biochemical Pharmacology · 1961 · 26.9K citations
KA-672 inhibits rat brain acetylcholinesterase in vitro but not in vivo
Michael Hilgert, Michael Nöldner, S. S. Chatterjee et al. · Neuroscience Letters · 1999 · 35 citations